A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice
We previously demonstrated that a subset of acute myeloid leukemia (AML) patients with concurrent RAS pathway and TP53 mutations have an extremely poor prognosis and that most of these TP53 mutations are missense mutations. Here, we report that, in contrast to the mixed AML and T cell malignancy tha...
| 出版年: | The Journal of Clinical Investigation |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
American Society for Clinical Investigation
2023-12-01
|
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1172/JCI173116 |
